Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biogen -- Ignore unavailable to you. Want to Upgrade?

To: TelecosmFan who wrote (832)	1/8/1999 10:16:00 AM
From: William Partmann	Respond to of 1686

The litigation settlement was not mentioned in the report. Some highlights: << Investment opinion: C-2-2-9 to C-1-1-9>> << Avonex sales continues to be strong>> << Our 1999 and 200 EPS forecasts are increased fro $2.55 and $3.00 to $2.60 and $3.15>> <<Our 12-month price objective of $110 per share is derived by applying a 35 PE to our new 2000 EPS estimate.>> << In our view, the recent resignation of former CEO James Tobin will have minimal to no effect on the company's operations.>>